Skip to main content
Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · IEX Real-Time Price · USD
52.28
-1.71 (-3.17%)
May 17, 2024, 4:00 PM EDT - Market closed

Keros Therapeutics Revenue

Keros Therapeutics had revenue of $234.00K in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $83.00K. In the year 2023, Keros Therapeutics had annual revenue of $151.00K.

Revenue (ttm)
$234.00K
Revenue Growth
n/a
P/S Ratio
8,047.94
Revenue / Employee
$1,721
Employees
136
Market Cap
1.88B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023151.00K--
Dec 31, 20220--
Dec 31, 202120.10M--
Dec 31, 20200--
Dec 31, 201910.00M--
Dec 31, 201810.00M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BrightSpring Health Services 9.37B
Warby Parker 697.80M
NeoGenomics 610.66M
Catalyst Pharmaceuticals 411.35M
UFP Technologies 407.33M
Beam Therapeutics 360.91M
Agios Pharmaceuticals 29.40M
CG Oncology 539.00K
Revenue Rankings

KROS News

More News